Fibroadenoma screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 10: Line 10:
==References==
==References==
{{reflist|1}}
{{reflist|1}}
{{Soft tissue tumors and sarcomas}}
[[Category:Breast]]
[[Category:Breast]]
[[Category:Primary care]]
[[Category:Primary care]]

Revision as of 15:19, 17 October 2019

Fibroadenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibroadenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT Scan

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fibroadenoma screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibroadenoma screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibroadenoma screening

CDC on Fibroadenoma screening

Fibroadenoma screening in the news

Blogs on Fibroadenoma screening

Directions to Hospitals Treating Fibroadenoma

Risk calculators and risk factors for Fibroadenoma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for fibroadenoma.

Screening

There is insufficient evidence to recommend routine screening for fibroadenoma.

References

Template:WH Template:WS